Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, August 27, 2021
[ Fri, Aug 27th 2021
] - WOPRAI
[ Fri, Aug 27th 2021
] - WOPRAI
[ Fri, Aug 27th 2021
] - WOPRAI
[ Fri, Aug 27th 2021
] - WOPRAI
[ Fri, Aug 27th 2021
] - WOPRAI
[ Fri, Aug 27th 2021
] - WOPRAI
[ Fri, Aug 27th 2021
] - WOPRAI
[ Fri, Aug 27th 2021
] - WOPRAI
[ Fri, Aug 27th 2021
] - WOPRAI
[ Fri, Aug 27th 2021
] - WOPRAI
[ Fri, Aug 27th 2021
] - WOPRAI
[ Fri, Aug 27th 2021
] - WOPRAI
[ Fri, Aug 27th 2021
] - WOPRAI
[ Fri, Aug 27th 2021
] - WOPRAI
[ Fri, Aug 27th 2021
] - WOPRAI
[ Fri, Aug 27th 2021
] - WOPRAI
[ Fri, Aug 27th 2021
] - WOPRAI
[ Fri, Aug 27th 2021
] - WOPRAI
[ Fri, Aug 27th 2021
] - WOPRAI
Thu, August 26, 2021
[ Thu, Aug 26th 2021
] - WOPRAI
[ Thu, Aug 26th 2021
] - WOPRAI
[ Thu, Aug 26th 2021
] - WOPRAI
[ Thu, Aug 26th 2021
] - WOPRAI
[ Thu, Aug 26th 2021
] - WOPRAI
[ Thu, Aug 26th 2021
] - WOPRAI
[ Thu, Aug 26th 2021
] - WOPRAI
[ Thu, Aug 26th 2021
] - WOPRAI
[ Thu, Aug 26th 2021
] - WOPRAI
[ Thu, Aug 26th 2021
] - WOPRAI
Tiago Fauth Maintained (ASND) at Buy with Increased Target to $185 on, Aug 26th, 2021
Tiago Fauth of Credit Suisse, Maintained "Ascendis Pharma A/S" (ASND) at Buy with Increased Target from $178 to $185 on, Aug 26th, 2021.
Tiago has made no other calls on ASND in the last 4 months.
There are 2 other peers that have a rating on ASND. Out of the 2 peers that are also analyzing ASND, 0 agree with Tiago's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Tiago
- Liana Moussatos of "Wedbush" Maintained at Buy with Decreased Target to $189 on, Monday, June 14th, 2021
- Michelle Gilson of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $196 on, Tuesday, June 1st, 2021
